Aspire Biopharma Holdings, Inc.

Biotechnology • Healthcare • Estero, FL, United States • ASBPW (NCM)

Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.

415 592 7399 23150 Fashion Drive, Estero, FL 33928, United States

Stock Performance (90 Days)

Data through Dec 29, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements - Morris County NJ News | Daily Record

Morris County NJ News | Daily Record • Dec 25

Aspire Biopharma Holdings (ASBP) Stock on Dec. 15, 2025: Nasdaq Extension, FDA Pre‑IND Momentum, and Dilution Risks Investors Are Watching - ts2.tech

ts2.tech • Dec 15

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements - The News Journal

The News Journal • Dec 14

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements - Beaver County Times

Beaver County Times • Dec 12

Aspire Biopharma (Nasdaq: ASBP) advances licensing talks after 16 CPHI meetings - Stock Titan

Stock Titan • Nov 6

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Aspire Biopharma Holdings, Inc. had layoffs?

No layoff events have been recorded for Aspire Biopharma Holdings, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

What industry is Aspire Biopharma Holdings, Inc. in?

Aspire Biopharma Holdings, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Aspire Biopharma Holdings, Inc. a publicly traded company?

Yes, Aspire Biopharma Holdings, Inc. is publicly traded under the ticker symbol ASBPW on the NCM.

Where is Aspire Biopharma Holdings, Inc. headquartered?

Aspire Biopharma Holdings, Inc. is headquartered in Estero, FL, United States at 23150 Fashion Drive, Estero, FL 33928, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.